Research Focus

Former Employee. Research and Technology Management; Research Project Manager

Recent additions – View all

1. A phase II trial of temsirolimus plus low-dose weekly carboplatin and paclitaxel for recurrent/metastatic HNSCC

   Meeting Abstract

   Fury, M. G.; Xiao, H.; Baxi, S. S.; Sherman, E. J.; Smith-Marrone, S.; Ho, A. L.; Sima, C. S.; Nwankwo, O. G.; Haque, S.; Katabi, N.; more...
   Journal of Clinical Oncology (2014)

   Fulltext@MSK | Save
2. A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer

   Journal Article

   Fury, M. G.; Sherman, E.; Ho, A. L.; Xiao, H.; Tsai, F.; Nwankwo, O.; Sima, C.; Heguy, A.; Katabi, N.; Haque, S.; more...
   Cancer (2013)

   Fulltext@MSK | Save
3. A phase I study of temsirolimus plus carboplatin plus paclitaxel for patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC)

   Journal Article

   Fury, M. G.; Sherman, E.; Ho, A.; Katabi, N.; Sima, C.; Kelly, K. W.; Nwankwo, O.; Haque, S.; Pfister, D. G.
   Cancer Chemotherapy and Pharmacology (2012)

   Fulltext@MSK | Save